Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide

Speciale, Andrea; Marengo, Barbara; Traverso, Nicola; Cantoni, Claudia; Ravera, Silvia; Garbarino, Ombretta; Pronzato, Maria Adelaide; Domenicotti, Cinzia

doi:10.1016/j.freeradbiomed.2018.04.217

Record: found
Abstract: not found
Article: not found

Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide

Author(s): Andrea Speciale , Barbara Marengo , Nicola Traverso , Claudia Cantoni , Silvia Ravera , Ombretta Garbarino , Maria Adelaide Pronzato , Cinzia Domenicotti

Publication date Created: May 2018

Publication date (Print): May 2018

Journal: Free Radical Biology and Medicine

Publisher: Elsevier BV

Read this article at

ScienceOpenPublisher

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Free Radical Biology and Medicine

Abbreviated Title: Free Radical Biology and Medicine

Publisher: Elsevier BV

ISSN (Print): 08915849

Publication date Created: May 2018

Publication date (Print): May 2018

Volume: 120

Page: S66

Article

DOI: 10.1016/j.freeradbiomed.2018.04.217

SO-VID: 257fedcf-cc64-4bd7-a2ec-fae690c0aa68

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_

Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide

Read this article at

Related collections

Stress signalling in stem cells

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 5,658